Herbaland Joint Care Liquid
Natural health product licensed in Canada
- Other names
- Herbaland Joint Health Liquid, Herbaland Joint/Bone Care Liquid, Herbaland Univestin Liquid
- Licence holder
- Herbaland Naturals Inc.
- NPN or DIN-HM
- 80148880
- Status
- Active licence
- Licence date
- 11 May 2026
- Revision date
- 22 May 2026
- Form
- Liquide oral
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Scutellaria baicalensis Extract : Matériel brut sec Extraction ratio : 15:1 Dry plant equivalent : 6 g Potency : 75 % Baicalin | 400 mg | Not calculated |
| Senegalia catechu Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 1.7 g Potency : 65 % Catechins | 85 mg | Not calculated |
| Collagène hydrolysé | 1,500 mg | Not calculated |
| Vitamine D Source : Cholécalciférol | 800 UI | Not calculated |
| Vitamine D Source : Cholécalciférol | 0.02 mg | Not calculated |
| Acide hyaluronique Source : Streptococcus equi - capsule extracellulaire bactérienne | 150 mg | Not calculated |
| Acide hyaluronique Source : Hyaluronate de sodium | 150 mg | Not calculated |
Non-medicinal ingredients
Maltodextrine, Eau purifiée, Jus de mangue, Maltitol, Saveur, Acide citrique, Rébaudioside M
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Portions | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in the development and maintenance of bones. Helps support joint health. Vitamin D intake, when combined with sufficient calcium, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Univestin® helps to relieve joint discomfort, stiffness and to improve mobility in persons suffering from osteoarthritis. Univestin® clinically proven to help improve decreased range of motion associated with osteoarthritis of the knee in 7 days. Univestin® starts to help to relieve joint discomfort associated with osteoarthritis of the knee in 5 days. Univestin® starts to help to reduce joint stiffness associated with osteoarthritis of the knee in 3 days. Provides antioxidants that help protect cell against the oxidative damage caused by free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80148880
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.